Immunomodulation of helicobacter infection

Canadian Journal of Gastroenterology

Volumn 13, Issue 3, 1999, Pages 237-241

  Croitoru, Ken ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Helicobacter pylori; Immune response; T cell

Indexed keywords

VACCINE;

BACTERIAL INFECTION; CELLULAR IMMUNITY; CONFERENCE PAPER; HELICOBACTER PYLORI; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; PRIORITY JOURNAL;

EID: 0032921206     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/839194     Document Type: Conference Paper

References (62)

1. Marshall BJ, Warren JR. Unidentified curved bacillus on gastric epithelium in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;i:1311-5.
2. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
3. Bardhan PK. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis 1997;25:973-8.
4. O'Brien B, Goeree R, Mohamed AH, Hunt R. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. Arch Intern Med 1995;155:1958-64.
5. Forman D. Essential co-factors in gastric carcinogenesis. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori. Basic Mechanisms to Clinical Cure 1996. Dordrecht: Kluwer Academic Publishers, 1996:255-61.
6. Graham DY. Can therapy ever be denied for Helicobacter pylori infection? Gastroenterology 1997;113:3113-7.
7. Fennerty MB. What are the treatment goals for Helicobacter pylori infection? Gastroenterology 1997;113:3120-5.
8. Lee J, O'Morain C. Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines. Gastroenterology 1997;113:399-106.
9. Marshall BJ. Helicobacter pylori in peptic ulcer: Have Koch's postulates been fulfilled? Ann Med 1995;27:565-8.
10. Croitoru K, Hunt R. Immunopathologie des infections a Helicobacter. In: Mege JL, Raoult D, Revillard JP, eds. Immunite et Infection: Concepts immunopathologiques et perspectives therapeutiques. Paris: Arnette, 1997:387-95.
11. Croitoru K, Snider DP. What determines the vigour of the immune response to Helicobacter pylori? In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori. Basic Mechanisms to Clinical Cure 1996. Dordrecht: Kluwer Academic Publishers, 1996:158-67.
12. Mitchell HM, Hu P, Chi Y, Chen MH, Li YY, Hazell SL. A low rate of reinfection following effective therapy against Helicobocter pylori in a developing nation (China). Gastroenterology 1998;114:256-61.
13. Croitoru K, Bienenstock J. Characteristics and functions of mucosa-associated lymphoid tissue. In: Ogra PL, Strober W, Mestecky J, McGhee JR, Lamm ME, Bienenstock J, eds. Handbook of Mucosal Immunology. San Diego: Academic Press, 1994:141-9.
14. Owen RL, Jones AL. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology 1974;66:189-203.
15. Bienenstock J, McDermott M, Befus D, O'Neill M. A common mucosal immunologic system involving the bronchus, breast and bowel. Adv Exp Med Biol 1978;107:53-9.
16. Kleanthous H, Myers GA, Georgakopoulos KM, et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun 1998;66:2879-86.
17. Trejdosiewicz LK, Calabrese A, Smart CJ, et al. Gamma/δ T cell receptor-positive cells of the human gastrointestinal mucosa: Occurrence and V region gene expression in Helicobacter pylori associated gastritis, coeliac disease and inflammatory bowel disease. Clin Exp Immunol 1991;84:440-4.
18. Genta RM, Hamner HW, Graham DY. Gastric lymphoid follicles in Helicobacter pylori infection: Frequency, distribution, and response to triple therapy. Hum Pathol 1993;24:577-83.
19. Bland PW, Kambarage DM. Antigen handling by the epithelium and lamina propria macrophages. Gastroenterol Clin North Am 1991;20:577-96.
20. Papadimitrou CS, Ioachim-Velogianni EE, Tsianos EB, Moutsopoulos HM. Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis. Virchows Arch A Pathol Anat Histopathol 1988;413:197-204.
21. Fan XJ, Crowe SE, Behar S, et al. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: A mechanism for T helper cell type 1-mediated damage. J Exp Med 1998;187:1659-69.
22. Sobala GM, Crabtree JE, Dixon MF, et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 1991;32:1415-8.
23. Hanson LÅ, Brandtzaeg P. The discovery of secretory IgA and the mucosal immune system. Immunol Today 1993;14:416-7.
24. Vajdy M, Koscos-Vilbois MH, Kopf M, Kohler G, Lycke N. Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med 1995;181:41-53.
25. Vaines K, Huitfeldt HS, Brandtzaeg P. Relation between T cell number and epithelial HLA class II expression quantified by image analysis in normal and inflamed human gastric mucosa. Gut 1990;31:647-52.
26. Negrini R, Lisato L, Zanella I, et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 1991;101:437-45.
27. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989;46:111-47.
28. Targan SR, Deem RL, Shanahan F. Role of mucosal T-cell-generated cytokines in epithelial cell injury. Immunol Res 1991;10:472-8.
29. Rubin JT, Lotze MT. Acute gastric mucosal injury associated with the systemic administration of interleukin-4. Surgery 1992;111:274-80.
30. Karttunen R, Karttunen T, Ekre HP, MacDonald TT. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995;36:341-5.
31. Bamford KB, Fan XJ, Crowe SE, et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998;114:482-92.
32. Crabtree JE, Farmery SM, Lindley IJD, Figura N, Peichl P, Tompkins DS. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994;47:945-50.
33. Crowe SE, Alvarez L, Dytoc M, et al. Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 1995;108:65-74.
34. McKay DM, Croitoru K, Perdue MH. T cell-monocyte interactions regulate epithelial physiology in a coculture model of inflammation. Am J Physiol 1996;270:C418-28.
35. McKay DM, Benjamin M, Baca-Estrada M, D'Inca R, Croitoru K, Perdue MH. Role of T lymphocytes in secretory response to an enteric nematode parasite: Studies in athymic rats. Dig Dis Sci 1995;40:331-7
36. Collins SM, Croitoru K. The pathophysiology of inflammatory bowel disease: The effect of inflammation on intestinal function. In: Targan S, Shanahan F, eds. Inflammatory Bowel Disease: From Bench to Bedside. Baltimore: Williams &. Wilkins, 1993:194-209.
37. Muller MJ, Padol I, Ernst PB, Croitoru K, Hunt RH. Interferon-gamma inhibits secretagogue-mediated acid secretion in isolated murine gastric glands. Gastroenterology 1993;104:A151. (Abst)
38. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor α and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473-7.
39. Fan X-G, Chua A, Fan X-J, et al. Increased gastric production of interleukin-8 and tumour necrosis factor in patients with Helicobacter pylori infection. J Clin Pathol 1995;48:133-6.
40. Tummuru MKR, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 1995;18:867-76.
41. Karita M, Kouchiyama T, Okita K, Nakzawa T. New small animal model of human gastric Helicobacter pylori infection: Success in both nude and euthymic mice. Am J Gastroenterol 1991;86:1596-603.
42. Michetti P, Corthésy-Theulaz I, Davin C, et al. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 1994;107:1002-11.
43. Enno A, O'Rourke JL, Howlett CR, Jack A, Dixon MF, Lee A. MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis: A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol 1995;147:217-22.
44. Lee A, Fox JG, Otto G, Murphy J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 1990;99:1315-23.
45. Fox JG, Blanco M, Murphy JC, et al. Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun 1993;61:2309-15.
46. Lee CK, Weltzin R, Thomas WD Jr, et al. Oral immunization with recombinant Helicobocter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis 1995;172:161-72.
47. Bogstedt AK, Nava S, Wadstrom T, Hammarström L. Helicobacter pylori infections in IgA deficiency: Lack of role for the secretory immune system. Clin Exp Immunol 1996;105:202-4.
48. Morris A, Nicholson G. Ingestion of Campylobocter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987;82:192-9.
49. Rotter JI, Sones JQ, Samloff IM, et al. Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder. N Engl J Med 1979;300:63-6.
50. Blecker U, Keymolen K, Levy J, Vandenplas Y. Low prevalence of Helicobocter pylori in the acquired immunodeficiency syndrome. Am J Gastroenterol 1993;88:1294. (Lett)
51. Blanchard TG, Czinn SJ, Nedrud JG, Redline RW. Helicobacter-associated gastritis in SCID mice. Infect Immun 1995;63:1113-5.
52. Marshall BJ, Armstrong JA, McGechie DB. Attempt to fulfill Koch's postulate for pyloric Campylobacter. Med J Aust 1985;142:436-9.
53. Finkelman FD, Pearce EJ, Urban JF, Sher A. Regulation and biological function of helminth-induced cytokine response. Immunol Today 1991;12:A62-6.
54. Brandtzaeg P. History of oral tolerance and mucosal immunity. Ann NY Acad Sci 1996;778:1-27.
55. Croitoru K, Ernst PB. Leukocytes in the intestinal epithelium: An unusual immunological compartment revisited. Regional Immunol 1992;4:63-9.
56. Tosi MF, Sorensen RU, Czinn SJ. Cell-mediated immune responsiveness to Helicobacter pylori in healthy seropositive and seronegative adults. Immunol Infect Dis 1992;2:133-6.
57. Fan XJ, Chua A, Shahi CN, McDevitt J, Keeling PW, Kelleher D. Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonization. Gut 1994;35:1379-84.
58. Czinn SJ, Nedrud JG. Oral immunization against Helicobacter pylori. Infect Immun 1991;59:2359-63.
59. Corthésy-Theulaz I, Porta N, Glauser M, et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology 1995;109:115-21.
60. Cuenca R, Blanchard TG, Czinn SJ, et al. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology 1996;110:1770-5.
61. Snider DP. The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Crit Rev Immunol 1995;15:317-48.
62. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 1997;113:1848-57.